This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2002 Mar 16;359(9310):978-9.

doi: 10.1016/S0140-6736(02)08001-7.

Interferon alfa-2a for melanoma metastases

John M Kirkwood, Joseph G Ibrahim, Vernon K Sondak, Marc S Ernstoff, Merrick Ross

PMID: 11918944
DOI: 10.1016/S0140-6736(02)08001-7

Comment

Interferon alfa-2a for melanoma metastases

John M Kirkwood et al. Lancet. 2002.

. 2002 Mar 16;359(9310):978-9.

doi: 10.1016/S0140-6736(02)08001-7.

Authors

John M Kirkwood, Joseph G Ibrahim, Vernon K Sondak, Marc S Ernstoff, Merrick Ross

PMID: 11918944
DOI: 10.1016/S0140-6736(02)08001-7

No abstract available

PubMed Disclaimer

Comment in

Interferon as adjuvant treatment for melanoma.
Wheatley K, Ives N, Hancock B, Gore M. Wheatley K, et al. Lancet. 2002 Sep 14;360(9336):878. doi: 10.1016/S0140-6736(02)09986-5. Lancet. 2002. PMID: 12243953 No abstract available.

Comment on

Effect of long-term adjuvant therapy with interferon alpha-2a in patients with regional node metastases from cutaneous melanoma: a randomised trial.
Cascinelli N, Belli F, MacKie RM, Santinami M, Bufalino R, Morabito A. Cascinelli N, et al. Lancet. 2001 Sep 15;358(9285):866-9. doi: 10.1016/S0140-6736(01)06068-8. Lancet. 2001. PMID: 11567700 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information